Innovations in mice models is expected to drive the growth of global humanized mice model market during the forecast period
According to TechSci Research report, “Global Humanized Mice Model Market By Service (Breeding, Cryopreservation, Others), By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Others), By Immune Checkpoints (CD47, CD34, PBMC, Others), By Technology (Crispr/Cas9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies), By Application (Oncology Studies, Immunology and Inflammation Studies, Others), By End-use (Companies, Organizations, Academic and Research Institutes, Contract Research Organizations), By Region, Forecast & Opportunities, 2025”, the global humanized mice model market is expected to grow at an impressive CAGR during the forecast period on account of the growing consumption of personalized medicines. In addition to this, expanding pipeline of pharmaceutical and biopharmaceutical companies across the globe is expected to propel the market growth over the next few years. Besides, growing application of mice for research purpose such as for immunology and inflammation studies, central nervous system studies, among others, is further expected to fuel the market growth. Moreover, growing demand for mice model in cancer research so that genetic basis of tumor development and cancer progression can be studied, is further driving the market growth. However, there are certain factors that might act as major impediments to the growth of global mice model market during the forecast period such as growing concern for the wellbeing of animals coupled with increasing awareness pertaining to animal rights.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on " Global Humanized Mice Model market"
The global humanized mice model market is segmented based on service, type, immune checkpoints, technology, application, end use, company, company and region. Based on application, the market can be split into oncology studies, immunology and inflammation studies, diabetes studies, cardiovascular studies, central nervous system studies and other disease studies. Here, the oncology studies segment is expected to dominate the market during the forecast period. This dominance can be attributed to growing cancer research activities across the globe. Additionally, rapid innovation in mice models in order to meet the requirements for cancer research, is further contributing to the growing trend. Based on technology, the market can be fragmented into Crispr/Cas9, microinjection, embryonic stem cell injection, nuclear transfer and other technologies. Among these, the Crispr/Cas9 technology segment is expected to register high growth in the market in the next 5 years. This high growth of this segment can primarily be attributed to numerous advantages it offers such as ease of design, high efficiency, and relatively low cost. Owing to these advantages, CRISPR is the most widely used technique, which is leading to large market share of this segment.
Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories, Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic, Inc., Genoway, Creative Biolabd, Horizon Discovery Group, Ingenious Targeting Laboratory, Biocytogen, Taconic Biosciences and others are some of the leading players operating in global humanized mice model market. The companies operating in the market are coming with new developments in order to boost their market share.
Customers can also request for 10% free customization on this report.
“North America is expected to dominate in the humanized mice model market during the forecast period owing to surging focus on biomedical research in the region, predominantly in United States. Additionally, rising demand for monoclonal antibody production is further expected to spur the market growth. Furthermore, presence of large market players in the region are expected to create lucrative opportunities for the market growth over the coming years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Humanized Mice Model Market By Service (Breeding, Cryopreservation, Others), By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Others), By Immune Checkpoints (CD47, CD34, PBMC, Others), By Technology (Crispr/Cas9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies), By Application (Oncology Studies, Immunology and Inflammation Studies, Others), By End-use (Companies, Organizations, Academic and Research Institutes, Contract Research Organizations), By Region, Forecast & Opportunities, 2025”, has evaluated the future growth potential of global humanized mice model market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global humanized mice model market.
Browse Related Reports
Global Bioinformatics Market By Product & Services (Knowledge Management Tools, Bioinformatic Platforms & Bioinformatic Services), By Applications (Microbial Genome, Gene Engineering, Drug Development, Personalized Medicine, Omics & Others), By Sectors (Forensic Biotechnology, Medical Biotechnology, Academics, Environmental Biotechnology, Animal Biotechnology & Agriculture Biotechnology), By Region, Competition, Forecast & Opportunities, 2025
United States Regenerative Medicine Market By Type (Cell-based immunotherapy & Cell therapy products, Gene therapy products, Tissue-engineered products, Others), By Material (Biologically Derived Material, Synthetic Material, Pharmaceuticals, Genetically Engineered Material, Others), By Application (Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, Others), By Region, Forecast & Opportunities, 2025
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
No comments:
Post a Comment